Min Pa: Min Pa(max): Activity's type:

Ext	Pa	Pi	Pmax	Activity	Other Results	ID Pa_max
	0.957	0.003	0.957	Anticonvulsant	0.939 0.003 CID_93250
	0.678	0.002	0.766	Benzodiazepine agonist	0.766 0.002 CID_93250	CID_93250
	0.501	0.026	0.641	GABA C receptor rho-3 antagonist	0.641 0.005 CID_93250	CID_93250
	0.473	0.024	0.473	Nootropic	0.467 0.025 CID_93250
	0.262	0.009	0.649	GABA receptor agonist	0.649 0.003 CID_93250	CID_93250
	0.295	0.077	0.295	Interleukin 2 agonist
	0.157	0.008	0.646	GABA A receptor antagonist	0.646 0.003 CID_93250	CID_93250
	0.183	0.036	0.375	Sodium channel (voltage-gated) blocker	0.375 0.004 CID_93250	CID_93250
	0.153	0.009	0.638	GABA receptor antagonist	0.638 0.003 CID_93250	CID_93250
	0.231	0.094	0.322	Interleukin agonist	0.322 0.038 CID_93250	CID_93250
	0.169	0.036	0.212	Nav1.6 sodium channel blocker	0.212 0.016 CID_93250	CID_93250
	0.158	0.04	0.158	Pregnane X receptor agonist	0.154 0.046 CID_93250
	0.117	0.005	0.155	Secretase gamma inhibitor	0.155 0.004 CID_93250	CID_93250
	0.16	0.051	0.372	Sodium channel blocker	0.372 0.005 CID_93250	CID_93250
	0.116	0.012	0.167	Cannabinoid CB1 receptor antagonist	0.167 0.006 CID_93250	CID_93250
	0.113	0.024	0.274	Cannabinoid receptor antagonist	0.274 0.005 CID_93250	CID_93250
	0.092	0.004	0.123	Calcitonin gene-related peptide 1 receptor antagonist	0.123 0.003 CID_93250	CID_93250
	0.119	0.033	0.204	Potassium channel activator	0.204 0.008 CID_93250	CID_93250
	0.174	0.091	0.415	Anesthetic general	0.415 0.015 CID_93250	CID_93250
	0.117	0.035	0.118	Potassium channel (Voltage-sensitive) activator	0.118 0.033 CID_93250	CID_93250
	0.151	0.072	0.242	GABA C receptor rho-2 antagonist	0.242 0.013 CID_93250	CID_93250
	0.083	0.005	0.087	Pregnane X receptor antagonist	0.087 0.005 CID_93250	CID_93250
	0.18	0.107	0.387	Potassium channel blocker	0.387 0.025 CID_93250	CID_93250
	0.065	0.005	0.074	Calcitonin gene-related peptide antagonist	0.074 0.004 CID_93250	CID_93250
	0.114	0.065	0.2	Calcium channel (voltage-sensitive) blocker	0.2 0.017 CID_93250	CID_93250
	0.08	0.033	0.199	Nav1.7 sodium channel blocker	0.199 0.006 CID_93250	CID_93250
	0.055	0.018	0.144	Benzodiazepine antagonist	0.144 0.003 CID_93250	CID_93250
	0.135	0.098	0.146	MAP kinase kinase 4 inhibitor	0.146 0.07 CID_93250	CID_93250
	0.085	0.05	0.086	Transforming growth factor beta 3 antagonist	0.086 0.046 CID_93250	CID_93250
	0.062	0.031	0.062	Aldose reductase inhibitor
	0.063	0.036	0.108	Potassium channel intermediate-conductance Ca-activated blocker	0.108 0.007 CID_93250	CID_93250
	0.068	0.043	0.076	MDM2 inhibitor	0.076 0.025 CID_93250	CID_93250
	0.039	0.017	0.039	Purinergic P2Y2 antagonist
	0.038	0.017	0.063	Benzodiazepine receptor peripheral-type antagonist	0.063 0.005 CID_93250	CID_93250
	0.129	0.112	0.129	Polo-like kinase-3 inhibitor
	0.101	0.089	0.143	Beta amyloid protein antagonist	0.143 0.046 CID_93250	CID_93250
	0.038	0.03	0.106	Cholecystokinin antagonist	0.106 0.008 CID_93250	CID_93250
	0.093	0.086	0.095	5 Hydroxytryptamine antagonist	0.095 0.084 CID_93250	CID_93250
	0.074	0.068	0.085	MAP kinase 7 inhibitor	0.085 0.03 CID_93250	CID_93250
	0.028	0.026	0.028	Liver X receptor antagonist	0.028 0.026 CID_93250
	0.106	0.105	0.229	Calcium channel blocker	0.229 0.021 CID_93250	CID_93250
	0.034	0.034	0.102	Delayed rectifier potassium channel blocker	0.102 0.004 CID_93250	CID_93250
	0.058	0.058	0.082	5 Hydroxytryptamine 3A antagonist	0.082 0.029 CID_93250	CID_93250
	0.032	0.033	0.042	Potassium channel KCNQ activator	0.042 0.021 CID_93250	CID_93250
	0.032	0.033	0.042	Delayed rectifier potassium channel activator	0.042 0.021 CID_93250	CID_93250
	0.031	0.032	0.037	p53 inhibitor	0.037 0.023 CID_93250	CID_93250
	0.073	0.078	0.133	GABA A receptor agonist	0.133 0.019 CID_93250	CID_93250
	0.047	0.055	0.109	Cannabinoid CB1 receptor agonist	0.109 0.017 CID_93250	CID_93250
	0.026	0.036	0.081	Cholecystokinin A antagonist	0.081 0.012 CID_93250	CID_93250
	0.036	0.05	0.125	Cannabinoid CB2 receptor antagonist	0.125 0.01 CID_93250	CID_93250
	0.142	0.158	0.219	Antiamyloidogenic	0.219 0.087 CID_93250	CID_93250
	0.093	0.108	0.127	Calcium channel N-type blocker	0.127 0.055 CID_93250	CID_93250
	0.047	0.063	0.078	Calcium channel T-type blocker	0.078 0.023 CID_93250	CID_93250
	0.036	0.059	0.07	Purinergic P2X4 antagonist	0.07 0.009 CID_93250	CID_93250
	0.056	0.079	0.064	Calcium channel P-type blocker	0.064 0.044 CID_93250	CID_93250
	0.034	0.059	0.064	GABA B receptor antagonist	0.064 0.01 CID_93250	CID_93250
	0.032	0.057	0.149	Glutamate (mGluR5) antagonist	0.149 0.005 CID_93250	CID_93250
	0.03	0.057	0.036	5 Hydroxytryptamine 2B agonist	0.036 0.033 CID_93250	CID_93250
	0.037	0.065	0.044	Benzodiazepine inverse agonist	0.044 0.038 CID_93250	CID_93250
	0.073	0.101	0.102	Creatine kinase inhibitor	0.102 0.057 CID_93250	CID_93250
	0.165	0.201	0.246	Gastrin inhibitor	0.246 0.084 CID_93250	CID_93250
	0.081	0.116	0.096	MAP kinase 13 inhibitor	0.096 0.087 CID_93250	CID_93250
	0.04	0.078	0.068	TRPA1 antagonist	0.068 0.034 CID_93250	CID_93250
	0.101	0.143	0.115	Mannose-6-phosphate isomerase inhibitor	0.115 0.109 CID_93250	CID_93250
	0.016	0.061	0.033	Progesterone antagonist	0.033 0.026 CID_93250	CID_93250
	0.01	0.057	0.039	Cholecystokinin B antagonist	0.039 0.015 CID_93250	CID_93250
	0.045	0.092	0.056	5 Hydroxytryptamine 5A antagonist	0.056 0.054 CID_93250	CID_93250
	0.144	0.195	0.171	MAP-kinase-activated kinase 5 inhibitor	0.171 0.146 CID_93250	CID_93250
	0.071	0.125	0.125	5 Hydroxytryptamine 3A agonist	0.125 0.052 CID_93250	CID_93250
	0.102	0.158	0.168	NOS3 expression enhancer	0.168 0.057 CID_93250	CID_93250
	0.029	0.087	0.128	Phosphodiesterase 2A inhibitor	0.128 0.005 CID_93250	CID_93250
	0.033	0.092	0.138	Phosphodiesterase II inhibitor	0.138 0.006 CID_93250	CID_93250
	0.058	0.117	0.184	Falcipain 2 inhibitor	0.184 0.017 CID_93250	CID_93250
	0.118	0.178	0.189	ATPase inhibitor	0.189 0.048 CID_93250	CID_93250
	0.059	0.121	0.185	Falcipain inhibitor	0.185 0.019 CID_93250	CID_93250
	0.178	0.242	0.214	Ca(v)3.3 blocker	0.214 0.163 CID_93250	CID_93250
	0.098	0.165	0.16	Cyclin-dependent kinase 8 inhibitor	0.16 0.07 CID_93250	CID_93250
	0.042	0.118	0.074	Nav1.8 sodium channel blocker	0.074 0.05 CID_93250	CID_93250
	0.065	0.143	0.119	GABA C receptor rho-1 antagonist	0.119 0.041 CID_93250	CID_93250
	0.042	0.12	0.188	Glutamate (mGluR group I) antagonist	0.188 0.009 CID_93250	CID_93250
	0.068	0.147	0.131	GABA C receptor antagonist	0.131 0.042 CID_93250	CID_93250
	0.029	0.108	0.105	Cannabinoid receptor agonist	0.105 0.024 CID_93250	CID_93250
	0.06	0.149	0.086	Bromodomain-containing protein 2 inhibitor	0.086 0.063 CID_93250	CID_93250
	0.027	0.119	0.05	5 Hydroxytryptamine 3 antagonist	0.05 0.049 CID_93250	CID_93250
	0.03	0.126	0.056	Androgen agonist	0.056 0.046 CID_93250	CID_93250
	0.225	0.331	0.368	Ca2+/calmodulin-dependent protein kinase kinase A inhibitor	0.368 0.131 CID_93250	CID_93250
	0.096	0.202	0.314	HERG channel blocker	0.314 0.045 CID_93250	CID_93250
	0.027	0.134	0.075	Purinergic P2 antagonist	0.075 0.036 CID_93250	CID_93250
	0.069	0.178	0.133	Nav1.5 sodium channel blocker	0.133 0.04 CID_93250	CID_93250
	0.038	0.151	0.216	Glutamate (mGluR) antagonist	0.216 0.009 CID_93250	CID_93250
	0.084	0.201	0.536	Sigma receptor agonist	0.536 0.007 CID_93250	CID_93250
	0.017	0.137	0.08	Cannabinoid CB2 receptor agonist	0.08 0.026 CID_93250	CID_93250
	0.081	0.242	0.316	Potassium channel (Voltage-sensitive) blocker	0.316 0.045 CID_93250	CID_93250
	0.016	0.185	0.067	Purinergic P2X antagonist	0.067 0.019 CID_93250	CID_93250
	0.088	0.269	0.16	Ca2+/calmodulin-dependent kinase II beta inhibitor	0.16 0.116 CID_93250	CID_93250
	0.136	0.337	0.507	Analgesic	0.507 0.047 CID_93250	CID_93250
	0.048	0.261	0.358	Psychostimulant	0.358 0.03 CID_93250	CID_93250
	0.056	0.28	0.111	Interleukin 8 antagonist	0.111 0.075 CID_93250	CID_93250
	0.104	0.359	0.351	Antiobesity	0.351 0.087 CID_93250	CID_93250
	0.027	0.307	0.25	Glutamate receptor antagonist	0.25 0.015 CID_93250	CID_93250
	0.04	0.516	0.176	Cardiotonic	0.176 0.144 CID_93250	CID_93250
Ext	Pa	Pi	Pmax	Activity	Other Results	ID Pa_max